With apologies in advance to the good folks at the Proceedings of the National Academy of Sciences (PNAS) for making a joke about something that could very well happen to any of us, we note the following correction: Continue reading Copy editor, stat! PNAS spells its editor-in-chief’s name wrong — on a piece he co-authored
Author: Ivan Oransky
IRB issues force retraction of ulcer bug bacteria paper
A group of Turkish researchers has had a paper retracted on how to treat the bacterium that cause ulcers after the journal’s editors found “issues related to the institutional review board approval” of the project.
Here’s the retraction notice from the Journal of Pediatric Gastroenterology and Nutrition: Continue reading IRB issues force retraction of ulcer bug bacteria paper
JAMA journal quietly replaces diabetes drug commentary after learning co-author is working for drugmaker
JAMA Internal Medicine has replaced a commentary they published last week on the risks of two diabetes drugs, but you wouldn’t know the new version was a replacement.
One change is a correction about whether Byetta and Januvia carry so-called “black box” warnings from the FDA. The original sentence:
Because both drugs already carry US Food and Drug Administration (FDA) black box warnings for the risk of pancreatitis, why is this study important?
It now reads: Continue reading JAMA journal quietly replaces diabetes drug commentary after learning co-author is working for drugmaker
Scientist whose work is “not fully supported by the available laboratory records” to retract 8 more papers
Yesterday, we reported that Sunil Kumar Manna, the head of immunology at India’s Centre for DNA Fingerprinting and Diagnostics, had retracted two papers for image problems.
Turns out Manna will be retracting eight more, he told us today. Here they are: Continue reading Scientist whose work is “not fully supported by the available laboratory records” to retract 8 more papers
Retraction count for gynecologic cancer researcher Takai grows to seven
Noriyuki Takai, a gynecologic cancer researcher at Oita University in Japan who retracted three papers last October, has four more retractions, these in Cancer Letters.
All but one of the notices reads as follows: Continue reading Retraction count for gynecologic cancer researcher Takai grows to seven
And then there were eight: Three more retractions for Alirio Melendez, all in the Journal of Immunology
Alirio Melendez, who has already retracted five papers and was found by one of his former universities to have committed misconduct on more than 20, has three more retractions.
Here’s the notice for “Antisense Knockdown of Sphingosine Kinase 1 in Human Macrophages Inhibits C5a Receptor-Dependent Signal Transduction, Ca2+ Signals, Enzyme Release, Cytokine Production, and Chemotaxis,” cited 68 times, according to Thomson Scientific’s Web of Knowledge: Continue reading And then there were eight: Three more retractions for Alirio Melendez, all in the Journal of Immunology
Two retractions for scientist whose work is “not fully supported by the available laboratory records”
The head of immunology at India’s Centre for DNA Fingerprinting and Diagnostics, Sunil Kumar Manna, has retracted two papers for image problems.
Here’s the notice from Cell Death and Differentiation for “Inhibition of RelA phosphorylation sensitizes apoptosis in constitutive NF-kappaB-expressing and chemoresistant cells:” Continue reading Two retractions for scientist whose work is “not fully supported by the available laboratory records”
Need more material for your paper under review? Just take it from someone else’s conference presentation
Let’s say you’re a researcher who’s just gotten reviews back from your latest manuscript, asking for some revisions. Luckily, you find yourself at a conference and spot a presentation that’s related to your work. So you use a bunch of that presentation material in your paper.
Unfortunately for you, the guy who gave that conference presentation sees your paper when it’s published — and he’s justifiably unhappy enough to contact the editors. Continue reading Need more material for your paper under review? Just take it from someone else’s conference presentation
After three retractions, five expressions of concern, cardiologist Matsubara resigns post
Hiroaki Matsubara, a leading Japanese cardiology researcher who has had three papers retracted and another five subject to expressions of concern, has resigned from Kyoto Prefectural University, according to local media.
Mainichi Shimbun reports — according to our roughest of (Google) translations — that Kyoto Prefectural University accepted Matsubara’s resignation following an investigation. That investigation — which the university had told us about last year — revealed serious problems with 27 studies.
As we noted last March: Continue reading After three retractions, five expressions of concern, cardiologist Matsubara resigns post
Another correction for Rui Curi, whose legal threats helped force shutdown of Science Fraud site
The Journal of Endocrinology has run a correction for a paper by Rui Curi, the Brazilian scientist whose lawyers threatened Science-Fraud.org after the site ran a number of posts critical of Curi’s work.
Here’s the notice for “Non-esterified fatty acids and human lymphocyte death: a mechanism that involves calcium release and oxidative stress”: Continue reading Another correction for Rui Curi, whose legal threats helped force shutdown of Science Fraud site